Berlin, I., et al. "[Lack of efficacy of yohimbine in the treatment of obesity]." Journal de pharmacologie 17.3 (1985): 343-347.
Galitzky, J., et al. "α2‐Antagonist compounds and lipid mobilization: evidence for a lipid mobilizing effect of oral yohimbine in healthy male volunteers." European journal of clinical investigation 18.6 (1988): 587-594.
Galitzky, J., et al. "Role of vascular alpha-2 adrenoceptors in regulating lipid mobilization from human adipose tissue." Journal of Clinical Investigation 91.5 (1993): 1997.
Lafontan, Max, et al. "Alpha-2 adrenoceptors in lipolysis: alpha 2 antagonists and lipid-mobilizing strategies." The American journal of clinical nutrition 55.1 (1992): 219S-227S.
Lönnqvist, F., et al. "Catecholamine-induced lipolysis in adipose tissue of the elderly." Journal of Clinical Investigation 85.5 (1990): 1614.
Ostojic, Sergej M. "Yohimbine: the effects on body composition and exercise performance in soccer players." Research in Sports Medicine 14.4 (2006): 289-299.
Sax, L. "Yohimbine does not affect fat distribution in men." International journal of obesity 15.9 (1991): 561-565.
Shim, Andrew, et al. "Assessing Various Body Composition Measurements as An Appropriate Tool for Estimating Body Fat in National Collegiate Athletic Association Division I Female Collegiate Athletes." American Journal of Sports Science and Medicine 2.1 (2014): 1-5.
Tam, S. William, Manuel Worcel, and Michael Wyllie. "Yohimbine: a clinical review." Pharmacology & therapeutics 91.3 (2001): 215-243.
Waluga, Marek, et al. "Cardiovascular effects of ephedrine, caffeine and yohimbine measured by thoracic electrical bioimpedance in obese women." Clinical Physiology 18.1 (1998): 69-76.
Zahorska-Markiewicz, B., C. Kucio, and D. Piskorska. "Adrenergic control of lipolysis and metabolic responses in obesity." Hormone and metabolic research 18.10 (1986): 693-697.